Literature DB >> 16272755

Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus.

Akiko Matsui-Sakata1, Hisakazu Ohtani, Yasufumi Sawada.   

Abstract

OBJECTIVE: Among various adverse reactions of atypical antipsychotics, weight gain and impaired glucose tolerance are clinically significant. The aim of this study is to analyze quantitatively the contributions of various receptors to these antipsychotics-induced adverse reactions based on the receptor occupancy theory.
METHODS: Two indices of antipsychotics-induced weight gain (the values estimated by a meta-analysis and the observed values in clinical trials) and the morbidity rate of type 2 diabetes mellitus during treatment with antipsychotics were taken from the literature. We calculated the estimated mean receptor occupancies of alpha1 adrenergic, alpha2 adrenergic, dopamine D2, histamine H1, muscarinic acetylcholine (mACh), serotonin 5-HT1A, 5-HT2A and 5-HT2C receptors by antipsychotics by using the pharmacokinetic parameters and receptor dissociation constants, and analyzed the correlation between the occupancies and the extent of adverse reactions as assessed using the aforementioned indices.
RESULTS: There were statistically significant correlations between the estimated occupancies of H1 and mACh receptors and antipsychotics-induced weight gain estimated by meta-analysis (r(s) = 0.81 and r(s) = 0.83, respectively, p < 0.01). There were also statistically significant correlations between these receptor occupancies and observed weight gain in clinical trials (r(s) = 0.66 in each case, p < 0.01). The morbidity rate of type 2 diabetes mellitus was highly correlated with H1, mACh, and 5-HT2C receptor occupancies (r(s) = 0.90 in each case, p < 0.05). However, H1 receptor occupancy was also highly correlated with mACh receptor occupancy among antipsychotics, so that only one of them may be critically associated with the adverse reactions. Considering that these adverse reactions have not been reported for drugs with mACh receptor antagonistic action, other than antipsychotics, the H1 receptor may contribute predominantly to the antipsychotics-induced weight gain and diabetes mellitus. DISCUSSION/
CONCLUSION: Model analysis based on receptor occupancy indicates that H1 receptor blockade is the primary cause of antipsychotics-induced weight gain and diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272755     DOI: 10.2133/dmpk.20.368

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  57 in total

1.  Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase.

Authors:  Goro Takami; Miyuki Ota; Akira Nakashima; Yoko S Kaneko; Keiji Mori; Toshiharu Nagatsu; Akira Ota
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

2.  Safety and tolerability of antipsychotic polypharmacy.

Authors:  Juan A Gallego; Jimmi Nielsen; Marc De Hert; John M Kane; Christoph U Correll
Journal:  Expert Opin Drug Saf       Date:  2012-05-08       Impact factor: 4.250

3.  Meal-induced insulin sensitization is preserved after acute olanzapine administration in female Sprague-Dawley rats.

Authors:  Diána Kovács; Csaba Hegedűs; Rita Kiss; Réka Sári; József Németh; Zoltán Szilvássy; Barna Peitl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-03       Impact factor: 3.000

4.  The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis.

Authors:  Joya N Hampton; Hanan D Trotman; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Ming T Tsuang; Diana O Perkins; Larry J Seidman; Scott W Woods; Elaine F Walker
Journal:  Stress Health       Date:  2018-06-28       Impact factor: 3.519

Review 5.  Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.

Authors:  Bart A A Franx; Ilse A C Arnoldussen; Amanda J Kiliaan; Deborah R Gustafson
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

Review 6.  Atypical antipsychotics and diabetic ketoacidosis: a review.

Authors:  Melanie D Guenette; Margaret Hahn; Tony A Cohn; Celine Teo; Gary J Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

Review 7.  Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.

Authors:  Katrina Weston-Green; Xu-Feng Huang; Chao Deng
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

Review 8.  [Genetics of weight gain associated with antipsychotic medications].

Authors:  D J Müller; C Peter; I Puls; E J Brandl; U E Lang; J Gallinat; A Heinz
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

9.  Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Authors:  D E Adkins; K Aberg; J L McClay; J Bukszár; Z Zhao; P Jia; T S Stroup; D Perkins; J P McEvoy; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2010-03-02       Impact factor: 15.992

10.  Expression changes of hypothalamic Ahi1 in mice brain: implication in sensing insulin signaling.

Authors:  Shaona Niu; Hao Wang; Zhenbo Huang; Xiurong Rao; Xiangsheng Cai; Tao Liang; Jing Xu; Xingshun Xu; Guoqing Sheng
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.